Latest Insider Transactions at Arrowhead Pharmaceuticals, Inc. (ARWR)
This section provides a real-time view of insider transactions for Arrowhead Pharmaceuticals, Inc. (ARWR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ARROWHEAD PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ARROWHEAD PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 07
2020
|
Douglas B Given Director |
SELL
Bona fide gift
|
Direct |
31,000
-20.02%
|
-
|
Dec 04
2020
|
Patrick O'Brien COO and General Counsel |
SELL
Bona fide gift
|
Direct |
800
-0.23%
|
-
|
Nov 20
2020
|
Curt Bradshaw Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
15,625
-100.0%
|
$1,062,500
$68.73 P/Share
|
Nov 19
2020
|
Curt Bradshaw Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
15,625
-50.0%
|
$1,078,125
$69.39 P/Share
|
Nov 19
2020
|
Martin Javier San Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
19,500
-13.0%
|
$1,345,500
$69.39 P/Share
|
Nov 09
2020
|
Kenneth Allen Myszkowski Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
43,505
-4.73%
|
$3,001,845
$69.45 P/Share
|
Nov 09
2020
|
Kenneth Allen Myszkowski Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
43,505
+8.45%
|
$609,070
$14.54 P/Share
|
Oct 23
2020
|
Christopher Richard Anzalone Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
100,000
-1.93%
|
$5,800,000
$58.37 P/Share
|
Oct 20
2020
|
Kenneth Allen Myszkowski Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
29,166
-6.38%
|
$1,574,964
$54.04 P/Share
|
Oct 20
2020
|
Kenneth Allen Myszkowski Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
29,166
+6.0%
|
$174,996
$6.15 P/Share
|
Oct 09
2020
|
Mauro Ferrari Director |
SELL
Open market or private sale
|
Direct |
10,000
-24.41%
|
$480,000
$48.0 P/Share
|
Oct 08
2020
|
Marianne De Backer Director |
BUY
Open market or private purchase
|
Direct |
1,000
+2.82%
|
$50,000
$50.47 P/Share
|